Showing 1 to 2 of 2 results


Gene Therapy Shows Promise in Frontotemporal Dementia Trials
A British company, AviadoBio, is conducting clinical trials of a gene therapy (AVB-101) for frontotemporal dementia (FTD-GRN), a genetic form of dementia, infusing a functional gene copy directly into the brain to restore progranulin protein levels; early trial data is expected next year.
Gene Therapy Shows Promise in Frontotemporal Dementia Trials
A British company, AviadoBio, is conducting clinical trials of a gene therapy (AVB-101) for frontotemporal dementia (FTD-GRN), a genetic form of dementia, infusing a functional gene copy directly into the brain to restore progranulin protein levels; early trial data is expected next year.
Progress
44% Bias Score

Dietary Changes: An Early Warning Sign for Dementia
Significant dietary shifts, like a lifelong vegetarian suddenly desiring meat, may be early dementia indicators, particularly frontotemporal dementia (FTD) affecting those under 65; this impacts families and increases the already substantial £42 billion annual UK dementia cost.

Dietary Changes: An Early Warning Sign for Dementia
Significant dietary shifts, like a lifelong vegetarian suddenly desiring meat, may be early dementia indicators, particularly frontotemporal dementia (FTD) affecting those under 65; this impacts families and increases the already substantial £42 billion annual UK dementia cost.
Progress
36% Bias Score
Showing 1 to 2 of 2 results